145 related articles for article (PubMed ID: 15528884)
1. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.
Gadelha T; André C; Jucá AA; Nucci M
Cerebrovasc Dis; 2005; 19(1):49-52. PubMed ID: 15528884
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years.
Koopman K; Uyttenboogaart M; Vroomen PC; van der Meer J; De Keyser J; Luijckx GJ
Thromb Haemost; 2009 Oct; 102(4):620-2. PubMed ID: 19806246
[TBL] [Abstract][Full Text] [Related]
6. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
7. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
8. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
9. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.
Souto JC; Coll I; Llobet D; del Río E; Oliver A; Mateo J; Borrell M; Fontcuberta J
Thromb Haemost; 1998 Sep; 80(3):366-9. PubMed ID: 9759610
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.
Ventura P; Cobelli M; Marietta M; Panini R; Rosa MC; Salvioli G
Cerebrovasc Dis; 2004; 17(2-3):153-9. PubMed ID: 14707415
[TBL] [Abstract][Full Text] [Related]
11. Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease.
Ateş A; Düzgün N; Ulu A; Tiryaki AO; Akar N
Pathophysiol Haemost Thromb; 2003; 33(3):157-63. PubMed ID: 15170396
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.
Kennedy M; Andreescu AC; Greenblatt MS; Jiang H; Thomas CA; Chassereau L; Wong C; Durda P; Cushman M
Br J Haematol; 2005 Feb; 128(3):386-8. PubMed ID: 15667542
[TBL] [Abstract][Full Text] [Related]
13. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
14. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
16. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
19. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
